logo
Construction, decimation of green cover turning Kol into urban heat island: Study

Construction, decimation of green cover turning Kol into urban heat island: Study

Time of India22-04-2025

1
2
3
Kolkata: The soaring summer heat is linked to shrinking green cover and rising built-up areas, according to a report by the Centre for Science and Environment (CSE).
Summers in Kolkata are becoming increasingly unbearable, not just because of rising mercury but due to the city's rapidly transforming landscape. The report highlights that unchecked urban expansion, shrinking green space and diminishing water bodies are altering the city's natural ability to stay cool, turning it into a heat trap.
CSE, a Delhi-based environmental think tank, conducted a study from 2001 to 2023, analysing land surface temperatures and humidity trends across six megacities — Delhi, Mumbai, Kolkata, Hyderabad, Bengaluru, Chennai — and four smaller cities — Chandigarh, Jaipur, Lucknow and Pune. The findings reveal a disturbing trend: urban areas are becoming heat zones, with heatwaves growing more intense.
In Kolkata, the study found that the built-up area, which includes concrete infrastructure and roads, rose sharply from 70% in 2001 to 80.1% in 2023. In contrast, green cover, crucial for temperature regulation, slightly declined from 15.2% to 14.5%. Alarmingly, scrubland and barren land, which earlier acted as buffer zones, plummeted from 9.8% to 3.4%, and water bodies reduced by more than half — from 5.1% to 1.9%.
These changes are key contributors to the Urban Heat Island (UHI) effect, where densely built-up urban areas retain more heat than their surroundings. With less vegetation and water to moderate temperatures, heat lingers well into the night, increasing public health risks, particularly during summer and monsoon months.
What makes Kolkata's heat even more punishing is its high humidity. The CSE report underscores that humidity has become a major driver of urban heat stress, particularly in coastal cities like Kolkata and Mumbai. The Heat Index — a measure of how hot it feels when relative humidity is factored in — has skyrocketed. In cities like Chennai, humidity added nearly 7°C to the perceived temperature. Kolkata, with its already high humidity levels, now frequently crosses thresholds that cause extreme heat stress.
CSE's analysis utilised satellite data from Landsat 7 and 8, focusing on the Normalised Difference Vegetation Index (NDVI) to assess green cover during India's hottest months — April to June. NDVI readings showed a consistent decline in vegetation, particularly during heatwave periods, correlating directly with the city's rising thermal stress. The reduced green cover means the city has lost its natural heat-mitigation shield, accelerating the impact of climate change at a hyperlocal level.
The CSE report makes it clear: India's cities are becoming hotter, wetter, and more dangerous, particularly for vulnerable populations. Without a clear and immediate shift in urban planning — focused on restoring green cover, conserving water bodies, and limiting unplanned construction — the situation is set to worsen.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program
RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program

Fashion Value Chain

timean hour ago

  • Fashion Value Chain

RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program

RenaissThera Private Limited ('RenaissThera'), a Bengaluru-based biotechnology company, announced a major milestone in its obesity drug discovery program targeting the glucose-dependent insulinotropic polypeptide receptor (GIPR). GIPR, an incretin receptor, is a validated target for peptide-based parenteral therapies where both stimulation and inhibition has shown efficacy in treating obesity and its co-morbidities. RenaissThera is developing novel, oral small molecules, both agonists and antagonists, as a more affordable and convenient alternative aiming to expand access for underserved populations in the global obesity market projected to reach USD 38 billion by 2032. Oral small molecules are more economical to manufacture and distribute than peptide-based obesity drugs. These molecules were designed and screened using proprietary AI and ML based platforms, followed by demonstrating in-vitro activity in cell lines and in-vivo activity to impact GIPR in mice to yield 'Hits'. RenaissThera now is advancing these Hits to the Lead optimization program to select candidates for pre-IND studies. RenaissThera is filing 'Composition of Matter' and utility patents for these oral novel small molecule GIPR modulators and continues to expand its innovation portfolio targeting GIP, GLP-1, and apelin receptors in obesity and diabetes. Its AI-powered Innovation Platform, integrating GenAI and machine learning tools, is accelerating the design and optimization of novel small molecules. 'We are grateful to our investors and collaborators for supporting us in reaching this milestone. Our team is focused on pushing candidates toward IND-readiness next year and we are in active discussions with potential pharma partners and investors interested in our obesity program,' said Dr. Ramkesh Meena, MD, CEO of RenaissThera. RenaissThera's progress was enabled through its collaboration with VedTechBio Research Private Limited which enabled access to its Agentic AI platform RxAgentAI and discovery expertise. 'We are very pleased with the outcomes of our collaboration with RenaissThera. This milestone further validates our platform and capabilities across key therapeutic areas including obesity, Type 2 diabetes, oncology, and inflammation,' said VedTechBio's Managing Director Sudhir Nagarajan. About RenaissThera RenaissThera is a Bengaluru-based biotech company developing affordable, AI-powered novel small-molecule therapies for high-unmet-need diseases like obesity and diabetes. Its goal is to innovate for underserved populations and expand global access to novel therapies. It leverages Indias CRO ecosystem for early-stage R&D to deliver globally relevant innovation. For more information

Small-cap stock below  ₹200 hits 52-week high upper circuit after THIS overseas business update
Small-cap stock below  ₹200 hits 52-week high upper circuit after THIS overseas business update

Mint

time2 hours ago

  • Mint

Small-cap stock below ₹200 hits 52-week high upper circuit after THIS overseas business update

Small-cap stock below ₹ 200: Aayush Wellness share price hit 52-week high by surging 2 per cent upper circuit in Tuesday's trading session to ₹ 154.05 apiece after the board approved the formation of wholly owned subsidiary in Singapore with an initial capital investment of SGD 10,000. The small-cap stock has gained over 51 per cent in last one month. In last one year, Aayush Wellness stock has given multibagger returns to its investors by ascending over 782 per cent. In a release dated June 9, the company said that this strategic expansion marks a significant step in the company's global growth strategy and will serve as a launchpad for its nutraceutical and healthcare products across the rapidly expanding Southeast Asian markets. 'Our new Singapore-based subsidiary will enable us to tap into one of the world's most dynamic wellness markets, offering greater agility in operations, regulatory efficiency, and direct access to high-growth ASEAN economies. This is a critical step toward building a global wellness brand," Naveena Kumar, Managing Director of Aayush Wellness said. The company further said that the expansion would focus on the following areas - Localizing product offerings to align with regulatory and cultural preferences, forging strategic partnerships and e-commerce distribution channels across ASEAN, driving export growth from India while expanding the company's international brand presence, establishing a regional R&D and innovation hub to adapt to market-specific wellness trends. ' This development is in line with Aayush Wellness Limited's broader mission to deliver science-backed, sustainable, and natural healthcare solutions globally. The company aims to use its new presence in Singapore to not only access markets in Malaysia, Indonesia, Thailand, and Vietnam, but also to establish a foundation for future global partnerships and innovation,' the company said. Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions.

Harvard gastroenterologist shares worst foods that could raise your cancer risk: Here's what to avoid
Harvard gastroenterologist shares worst foods that could raise your cancer risk: Here's what to avoid

Hindustan Times

time2 hours ago

  • Hindustan Times

Harvard gastroenterologist shares worst foods that could raise your cancer risk: Here's what to avoid

While no single food directly causes cancer, certain dietary choices can significantly increase the risk. Dr. Saurabh Sethi, a California-based gastroenterologist trained at AIIMS, Harvard, and Stanford University, highlighted this in a June 9 Instagram post, where he revealed what he considers the worst food for cancer risk. (Also read: Gastroenterologist shares 7 common everyday habits that could be silently ruining your gut health ) "Did you know that some of the most common everyday foods are scientifically linked to increased cancer risk? Here are some major food culprits that you must reduce or eliminate from your diet, especially if you're serious about long-term health," Dr Sethi wrote in the caption. Let's take a closer look at what he recommends: A post shared by Saurabh Sethi (@ These include items like sausages, hot dogs, bacon, and deli meats. Rich in preservatives and additives like nitrates and nitrites, they have been classified as Group 1 carcinogens by the World Health Organisation, the same category as tobacco. Regular consumption of sodas, energy drinks, and sweetened beverages can spike insulin levels, lead to weight gain, and increase inflammation, all of which are known to support cancer cell growth and progression. Foods that are deep-fried in reused or heavily processed oils produce harmful compounds like acrylamide and trans fats. These not only promote inflammation but also create oxidative stress in the body, both linked to higher cancer risk. Cooking meats at high temperatures, especially over an open flame, can create carcinogenic compounds such as heterocyclic amines (HCAs) and polycyclic aromatic hydrocarbons (PAHs), which have been shown to damage DNA and potentially trigger cancerous mutations. Even moderate alcohol intake has been linked to an increased risk of breast, liver, and colorectal cancers. Alcohol can disrupt hormone levels, particularly estrogen, and also produce a toxic byproduct called acetaldehyde, which damages DNA. Packaged snacks, ready-to-eat meals, instant noodles, and sugary cereals often contain high levels of refined carbohydrates, added sugars, and industrial seed oils. These ingredients can drive systemic inflammation, which is a known precursor to many chronic illnesses, including cancer. Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store